Burkitt lymphoma is a highly aggressive form of non-Hodgkin lymphoma characterized by rapid tumor growth. When it involves the intrathoracic lymph nodes, it can lead to significant respiratory distress and systemic symptoms. Accurate coding with ICD-10 Code C83.72 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively manage and treat this serious condition.
ICD-10 Code C83.72 specifically denotes Burkitt lymphoma affecting the intrathoracic lymph nodes. This aggressive lymphoma is associated with rapid cell proliferation and can lead to severe complications if not promptly diagnosed and treated. This code should be used in clinical documentation and billing when a patient presents with symptoms indicative of this condition, ensuring accurate representation of the patient's diagnosis.
Burkitt lymphoma, particularly when localized to the intrathoracic lymph nodes, is a critical condition that necessitates immediate medical intervention. It is characterized by the proliferation of B-lymphoid cells and can progress rapidly, leading to significant morbidity. Early recognition and treatment are vital to improve patient outcomes.
In SOAP notes, ICD-10 Code C83.72 is utilized to document the diagnosis of Burkitt lymphoma affecting the intrathoracic lymph nodes. This code aids in capturing the patient's symptoms, assessment findings, and treatment plans, ensuring comprehensive documentation in both acute and chronic care settings.
ICD-10 Code C83.72 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of Burkitt lymphoma in the intrathoracic lymph nodes. This code is crucial for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.
Burkitt lymphoma requires urgent treatment due to its aggressive nature. Hospitalization is often necessary for intensive therapy.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C83.72 is critical for accurate billing in hospital, ER, or infectious disease care settings.
| CPT Code | Description |
|---|---|
| 96413 | Chemotherapy administration, intravenous, push, single or initial substance. |
| 99223 | Initial hospital care, typically 70 minutes or more. |
| 85025 | Complete blood count (CBC) with automated differential. |
| 77021 | Magnetic resonance imaging (MRI) of the chest. |
Common Questions About Using ICD-10 Code C83.72 for Burkitt lymphoma, intrathoracic lymph nodes
What are the common symptoms of Burkitt lymphoma?
Common symptoms include rapidly enlarging lymph nodes, fever, night sweats, weight loss, and respiratory distress due to intrathoracic involvement.
How is Burkitt lymphoma diagnosed?
Diagnosis typically involves imaging studies, biopsy of affected lymph nodes, and histological examination to confirm the presence of Burkitt lymphoma cells.
What is the treatment for Burkitt lymphoma?
Treatment usually consists of intensive chemotherapy regimens, and in some cases, radiation therapy may be indicated depending on the disease stage.
Is Burkitt lymphoma contagious?
No, Burkitt lymphoma is not contagious. It is a type of cancer that arises from genetic mutations in B-lymphoid cells.
Clinical Notes
SOAP notes
DAP notes
AI medical notes